Galectin-3 for risk stratification in acute coronary syndrome

Turk Kardiyol Dern Ars. 2020 Nov;48(8):721-722. doi: 10.5543/tkda.2020.78277.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute Coronary Syndrome*
  • Biomarkers
  • Galectin 3*
  • Humans
  • Prognosis
  • Risk Assessment

Substances

  • Biomarkers
  • Galectin 3